OpGen
OPGN
$4.60
Share price
838.58%
Change (1 day)
513.33%
Change (1 year)
Categories
Earnings for OpGen (OPGN)
Earnings in 2023 (TTM): -$26.17 M
According to OpGen 's latest financial reports the company's current earnings (TTM) are -$26.17 M. In 2022 the company made an earning of -$37.29 M a decrease over its 2021 earnings that were of -$34.77 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for OpGen from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$26.17 M | -29.83% |
| 2022 | -$37.29 M | 7.25% |
| 2021 | -$34.77 M | 33.3% |
| 2020 | -$26.08 M | 109.52% |
| 2019 | -$12.45 M | -6.89% |
| 2018 | -$13.37 M | -13.3% |
| 2017 | -$15.42 M | -19.55% |
| 2016 | -$19.17 M | 9.64% |
| 2015 | -$17.49 M | 208.23% |
| 2014 | -$5.68 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | -$0.18 B | 577.01% | 🇺🇸 USA |
 Enzo Biochem ENZ | -$9.61 M | -63.29% | 🇺🇸 USA |